AUD Archives - AMERSA

New in SAj: Barriers and facilitators to changing drinking and receiving alcohol-related care: Interviews with Veterans Health Administration primary care patients who indicated interest but did not enroll in an alcohol care management intervention trial

Jul 10, 2022 by AMERSA

Most people with alcohol use disorder do not receive treatment, and primary care (PC)-based management of alcohol use disorder is a key strategy to close this gap. Understanding PC patients’ perspectives on changing drinking and receiving alcohol-related care is important for this goal, particularly among those who decline alcohol-related care. This study examined perspectives on barriers and facilitators to changing drinking and receiving alcohol-related care among Veterans Health Administration (VA) PC patients who indicated interest but did not enroll in the Choosing Healthier drinking Options In primary CarE trial (CHOICE), which tested a PC-based alcohol care management intervention.

This original research paper comes from authors Madeline C. Frost, MPH,Theresa E. Matson, MPH, Julie E. Richards, PhD MPH, Amy K. Lee, MPH, Carol E. Achtmeyer, MN ARNP, Katharine A. Bradley, MD MPH, and Emily C. Williams, PhD MPH.

Read It Now!

New in SAj: Smartphone-based alcohol interventions: A systematic review on the role of notifications in changing behaviors toward alcohol

Jun 24, 2022 by AMERSA

The aim of “Smartphone-based alcohol interventions: A systematic review on the role of notifications in changing behaviors toward alcohol” was to assess the role of notifications in smartphone-based interventions designed to support, manage, or reduce alcohol consumption.

Charlotte Williamson, MSc, Katie White, BSc, Roberto J. Rona, PhD, Amos Simms, MSc, Nicola T. Fear, DPhil (OXON), Laura Goodwin, PhD, Dominic Murphy, PhD and Daniel Leightley, PhD conducted this review using 14 papers meeting inclusion criteria: (1) studies using a smartphone-based alcohol intervention, (2) the intervention used notifications, and (3) published between 1st January 2007 and 30th April 2021 in English.

This review was published in SAj Volume 43, Issue 1 on June 7, 2022. Read it now!

New in SAj: Cannabis and cocaine use, drinking outcomes, and quality of life in general hospital inpatients with alcohol use disorder

Jun 23, 2022 by AMERSA

Esperanza Romero-Rodríguez, MD MSc PhD, Clara A. Chen, MHS, Kimberly A. Dukes, PhD, Kaitlin Hartlage, MPH, Tibor P. Palfai, PhD, Kara M. Magane, MS, Jeffrey H. Samet, MD MA MPH and Richard Saitz, MD MPH assess associations between cannabis and cocaine use and two outcomes [heavy drinking days and quality of life] among hospital inpatients with an alcohol use disorder.

This brief report was just published in SAj Volume 43, Issue 1 on June 7, 2022. Read it now!

The Authors’ Own Words: Homelessness predicts attrition but not alcohol abstinence in outpatients experiencing co-occurring alcohol dependence and serious mental illness

Jan 17, 2020 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Homelessness predicts attrition but not alcohol abstinence in outpatients experiencing co-occurring alcohol dependence and serious mental illness

Emily Leickly, BA; Jordan Skalisky, BA; Oladunni Oluwoye, PhD; Sterling M. McPherson, PhD; Debra Srebnik, PhD; John M. Roll, PhD; Richard K. Ries, MD; & Michael G. McDonell, PhD

Substance Abuse Vol. 39, Iss. 3, 2018

“Individuals with serious mental illness receiving contingency management (CM) for alcohol dependence who were also experiencing homelessness had higher rates of CM attrition than those who were housed. However, homelessness was not associated with differences in EtG-assessed alcohol abstinence. Thus, CM could be a promising intervention for adults with co-occurring disorders provided homelessness-related participation barriers are addressed.”

The Authors’ Own Words: Integration of a Clinical Pharmacy Specialist into a Substance Use Disorder Intensive Outpatient Treatment Program to Improve Prescribing Rates of Alcohol Use Disorder Pharmacotherapy

Jan 6, 2020 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Integration of a Clinical Pharmacy Specialist into a Substance Use Disorder Intensive Outpatient Treatment Program to Improve Prescribing Rates of Alcohol Use Disorder Pharmacotherapy

Erica Dimitropoulos PharmD, Stephanie Bertucci LICSW; & Kara Wong PharmD, BCPP

Substance Abuse Vol. 39, Iss. 2, 2018

“The pharmacist’s role in the management of substance use disorders is not currently well defined. In an effort to explore this further, our study employed a bridge service that utilized pharmacists to improve access to evidence-based alcohol use disorder pharmacotherapy. Using this model, we were able to optimize treatment by offering medications to supplement psychotherapy for patients enrolled in an intensive outpatient program. Our intervention serves as an example for other facilities looking for novel ways to integrate pharmacists into substance use disorder clinics.”